Sartorius
5 Orville Drive, Suite 200
Bohemia
New York
11717
United States
59 articles with Sartorius
-
Resolutions of the Annual Shareholders' Meeting of Sartorius AG - Mar 26, 2021
3/26/2021
At virtual Annual General Shareholders' Meeting, shareholders granted discharge to the Executive Board and the Supervisory Board and approved the boards' proposals by a large majority.
-
Sartorius looks back on a very successful 2020 and expects further strong growth
2/18/2021
The life science group Sartorius confirmed its preliminary figures for 2020 upon the release of its annual report.
-
Sartorius closes 2020 with strong growth to well over 2 billion euros and a further increase in profitability
1/27/2021
Preliminary results for the full year of 2020: Order intake up 49.0 percent; sales revenue up 30.2 percent; underlying EBITDA margin climbs to 29.6 percent
-
Sartorius to acquire Novasep's chromatography process equipment division
1/6/2021
The life science company Sartorius announced it has entered into an agreement through its subgroup Sartorius Stedim Biotech to acquire the chromatography process equipment division of Novasep.
-
Sartorius Awards MyoGene Bio With $25,000 in Products and Services at QB3 Pitch Summit 2020
12/16/2020
Sartorius recently recognized startup company MyoGene Bio at the QB3 Pitch Summit, a competition showcasing promising new life science companies. This award provides the company with a $25,000 voucher that they can use for the purchase of any Sartorius products and services to support their development of a gene therapy for Duchenne muscular dystrophy (DMD). MyoGene Bio’s MyoDys 45-55 gene editing therapy uses CRISPR
-
Sartorius acquires filtration expert WaterSep BioSeparations
12/9/2020
- Transaction provides a complementary fit with Sartorius' separation portfolio, adding innovative crossflow filtration units for easy-to-use bioprocessing devices - Technology is especially suited to gene and cell therapy applications, vaccine production and intensified bioprocessing
-
Sartorius closes acquisition of BIA Separations
11/2/2020
The life science company Sartorius successfully closed the acquisition of the Slovenian purification specialist BIA Separations.
-
Strong profitable growth at Sartorius
10/20/2020
Nine-month results: Order intake1 up 37.8 percent; sales revenue up 25.2 percent; underlying EBITDA1 margin climbs to 29.1 percent
-
Purification specialist BIA Separations to become part of Sartorius
10/2/2020
The life science company Sartorius announced it has entered into a definitive agreement to merge purification specialist BIA Separations into its subgroup Sartorius Stedim Biotech in a transaction totaling 360 million euros of which 240 million euros will be paid in cash and 120 million euros in Sartorius Stedim Biotech shares.
-
Sartorius With Dynamic Growth in the First Half; 2020 Sales and Earnings Forecast Raised
7/21/2020
Successful first half: Order intake1 up 27.5 percent, Group sales revenue up 17.9 percent, underlying EBITDA1 margin reaches 27.8 percent
-
Sartorius Raises Forecast for the Full Year of 2020
7/15/2020
Stronger growth and higher profitability expected for the Bioprocess Solutions Division and the entire Group; outlook for the Lab Products & Services Division unchanged
-
Sartorius Off to a Dynamic Start in Fiscal 2020
4/21/2020
Group sales revenue up 16.5%; order intake up 29.7%; underlying EBITDA margin 27.0%
-
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 31, 2020.
-
BioSpace Global Roundup, March 26
3/26/2020
Pharma and life sciences companies from across the globe provide updates on their pipelines and business practices. -
Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials
3/25/2020
Sartorius has supported CanSino Biologics Inc. and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials.
-
A summary of daily biopharma industry news. Please check out stories that are trending on March 25, 2020.
-
European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius Stedim Biotech
3/20/2020
On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher life science businesses by Sartorius, SSB's major shareholder. Both approvals are an important milestone for the transaction originally announced in October 2019 , the co
-
European and U.S. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses by Sartorius
3/20/2020
On March 18 and March 19, 2020 respectively, the European Commission and the U.S. Federal Trade Commission cleared the proposed acquisition of select Danaher businesses by Sartorius. Both approvals are an important milestone for the transaction originally announced in October 2019 , the completion of which is still subject
-
Sartorius Postpones Annual Shareholders' Meeting
3/17/2020
Sartorius will postpone its Annual General Shareholders' Meeting formerly scheduled for March 26, 2020, to a later date due to the coronavirus pandemic and the associated restrictive rules imposed on meetings.
-
Sartorius Launches BIOSTAT STR® Generation 3 with BIOBRAIN - Making Biopharmaceutical Development and Production Faster, Simpler and Safer
3/9/2020
Engineered to address the rigorous requirements and complexity of biologics manufacture, Sartorius’ BIOSTAT STR® Generation 3 single-use bioreactor and BIOBRAIN automation platform introduce innovations that will change the field of biopharmaceutical process development and manufacturing.